These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2525905)

  • 1. Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5'-deoxy-5-fluorouridine against adenocarcinoma 755 in mice. Correlation with pharmacokinetics of plasma 5-fluorouracil levels.
    Iigo M; Nishikata K; Nakajima Y; Hoshi A; Okudaira N; Odagiri H; De Clercq E
    Biochem Pharmacol; 1989 Jun; 38(12):1885-9. PubMed ID: 2525905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal treatment regimens for 5'-deoxy-5-fluorouridine, with or without (E)-5-(2-bromovinyl)-2'-deoxyuridine, against various tumors in mice.
    Iigo M; Miwa M; De Clercq E
    Jpn J Cancer Res; 1990 Apr; 81(4):431-5. PubMed ID: 2142152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5-fluorouracil against adenocarcinoma 755 in mice. Increased therapeutic index and correlation with increased plasma 5-fluorouracil levels.
    Iigo M; Araki E; Nakajima Y; Hoshi A; De Clercq E
    Biochem Pharmacol; 1988 Apr; 37(8):1609-13. PubMed ID: 3358790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced antitumor effect of 5'-deoxy-5-fluorouridine by oral administration with L-cysteine.
    Iigo M; Nakajima Y; Araki E; Hoshi A
    Jpn J Cancer Res; 1989 Feb; 80(2):182-7. PubMed ID: 2524459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of acyclothymidine, a potent pyrimidine nucleoside phosphorylase inhibitor, on the pharmacokinetics of doxifluridine in rabbits via oral administration.
    Hamada A; Fukushima S; Morinaga A; Saneyoshi M; Kawaguchi T; Nakano M
    Biol Pharm Bull; 1993 Dec; 16(12):1297-300. PubMed ID: 8130783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative antitumor activity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in combination with radiation therapy in mice bearing colon 26 adenocarcinoma.
    Ishikawa T; Tanaka Y; Ishitsuka H; Ohkawa T
    Jpn J Cancer Res; 1989 Jun; 80(6):583-91. PubMed ID: 2527217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5'-deoxy-5-fluorouridine.
    Ooi A; Ohkubo T; Higashigawa M; Kawasaki H; Kakito H; Kagawa Y; Kojima M; Sakurai M
    Biol Pharm Bull; 2001 Nov; 24(11):1329-31. PubMed ID: 11725974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measurement of 5'-deoxy-5-fluorouridine (5'-DFUR) by high-performance liquid chromatography and studies on pharmacokinetics of 5'-DFUR and 5-fluorouracil by oral and intravenous administration].
    Hara Y; Kono A; Tanaka M
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2261-6. PubMed ID: 6237614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of 5'-deoxy-5-fluorouridine in human digestive organ cancer xenografts and pyrimidine nucleoside phosphorylase activity in normal and neoplastic tissues from human digestive organs.
    Nio Y; Kimura H; Tsubono M; Tseng CC; Kawabata K; Masai Y; Hayashi H; Meyer C; Fukumoto M; Tobe T
    Anticancer Res; 1992; 12(4):1141-6. PubMed ID: 1386969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the pharmacokinetics of 5'-deoxy-5-fluorouridine and 5-fluorouracil in rats by oral co-administration of acyclothymidine.
    Hamada A; Fukushima S; Saneyoshi M; Shimizu S; Kawaguchi T; Nakano M
    Biol Pharm Bull; 1996 May; 19(5):729-32. PubMed ID: 8741584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic effects of orally administered 5'-deoxy-5-fluorouridine, 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil on experimental murine tumors.
    Uehara N; Baba H; Nitta K; Kunimoto T; Takeuchi M; Sasaki T; Tanaka T
    Jpn J Cancer Res; 1985 Oct; 76(10):1034-41. PubMed ID: 2934356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition and availability of 5-fluorouracil prodrug 5'-deoxy-5-fluorouridine after oral administration in rats.
    Au JL
    J Pharm Sci; 1987 Sep; 76(9):699-702. PubMed ID: 11002805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The study of 5-FU levels and pyrimidine nucleoside phosphorylase (PyNPase) activity in human breast cancer tissue after administration of 5'-deoxy-5-fluorouridine (5'-DFUR)].
    Yayoi E; Takatsuka Y; Miyauchi K; Hirai T; Aikawa T; Maeura Y; Kaji M; Kitada M; Kotsuma Y; Satomi T
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1371-4. PubMed ID: 2142401
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of coadministered uridine on intestinal first-pass metabolism of 5'-deoxy-5-fluorouridine in conscious rats--an evaluation by method of portal-systemic concentration difference.
    Sawai Y; Yamaoka K; Nakagawa T
    Pharm Res; 1998 Jul; 15(7):1007-11. PubMed ID: 9688052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of a new fluoropyrimidine derivative, 5'-deoxy-5-fluorouridine, against murine and human experimental tumors.
    Fujimoto S; Wang Y; Inoue K; Ogawa M
    Jpn J Cancer Res; 1985 Jul; 76(7):644-50. PubMed ID: 3161854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Fluorouracil concentration in blood, liver and tumor tissues and apoptosis of tumor cells after preoperative oral 5'-deoxy-5-fluorouridine in patients with hepatocellular carcinoma.
    Zheng JF; Wang HD
    World J Gastroenterol; 2005 Jul; 11(25):3944-7. PubMed ID: 15991299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of a new anticancer drug galocitabine and its metabolites in blood by high-performance liquid chromatography.
    Funaki T; Onodera H; Ogawa K; Ichihara S; Fukazawa H; Kuruma I
    J Pharm Biomed Anal; 1993; 11(4-5):379-84. PubMed ID: 8357875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced antitumor activity of 5'-deoxy-5-fluorouridine against Lewis lung carcinoma in aged hybrid (C57BL/6 x DBA/2) F1 mice.
    Fujimoto S; Wang Y; Ogawa M
    J Pharmacobiodyn; 1987 Jun; 10(6):260-5. PubMed ID: 2959766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of 5-fluorouracil in plasma and liver after oral administration of 5'-deoxy-5-fluorouridine using gas chromatography-mass spectrometry.
    Odagiri H; Ichihara S; Semura E; Utoh M; Tateishi M; Kuruma I
    J Pharmacobiodyn; 1988 Apr; 11(4):234-40. PubMed ID: 2970537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of capecitabine and its three nucleoside metabolites in human plasma by high performance liquid chromatography-tandem mass spectrometry.
    Deng P; Ji C; Dai X; Zhong D; Ding L; Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 May; 989():71-9. PubMed ID: 25808944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.